Greek Registry - Familial Hypercholesterolaemia
Familial HypercholesterolemiaFamilial hypercholesterolemia (FH) [heterozygous (heFH) or homozygous FH (hoFH)] is a common genetic disorder, characterized by elevated plasma low density lipoprotein (LDL) cholesterol concentration leading (if untreated) to cholesterol deposits in the corneas, eyelids and extensor tendons, rapidly progressing vascular disease, and aortic valve disease.
Effects of Lomitapide on Carotid and Aortic Atherosclerosis
Homozygous Familial HypercholesterolemiaStudy to assess changes in carotid and aortic atherosclerosis in patients being treated with lomitapide.
Atherosclerosis in Familial Hypercholesterolemia
Familial HypercholesterolemiaFamilial hypercholesterolemia (FH) is a common inherited disorder with a frequency of 1 in 500 in the UK. Our aim is compare the carotid and coronary artery atherosclerosis in monogenic FH and polygenic hypercholesterolemia with means of a carotid ultrasound, a coronary CT angiogram and biochemical biomarkers.
Familial Hypercolerstremia as Risk Factor in Stemi Patient Who Underwent Ppci
Familial HypercholesterolemiaFamulial hypercolerstremia as risk factor
Aortic Stenosis in Subjects With Heterozygous Familial Hypercholesterolemia on Prolonged Treatment...
Aortic StenosisArteriosclerosis2 moreAortic stenosis (AE) is a disease that has been increasing steadily in recent years in most countries, including Spain.Risk factors for the development of AE include age, hypercholesterolemia, diabetes mellitus and arterial hypertension, the classic risk factors for the development of atherosclerosis. However, lipid-lowering therapy with statins and ezetimibe has not been shown to reduce the risk of long-term progression of AE by unknown mechanisms. All this suggests that subjects with HFhe have a high risk of developing AD, which has not been shown by the high coronary mortality in this population that precedes aortic calcification